Gifts
This page lists 234 references in the Main Healthy Skepticism Library relevant to Gifts.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL6316
McNeill PM, Kerridge IH, Henry DA, Stokes B, Hill SR, Newby D, MacDonald GM, Day RO, Maguire J, Henderson KM.
Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia
Internal Medicine Journal 2006 Sep 1;36:571
http://www.blackwell-synergy.com/doi/full/10.1111/j.1445-5994.2006.01151.x
HSL6321
Burton B.
Drug industry told to disclose details of doctors' events
BMJ 2006 Aug 5;333(7562):278
http://bmj.bmjjournals.com/cgi/content/extract/333/7562/278-b
HSL6842
Federman DG.
Pens, trips, and the public trust: support for stronger action.
Conn Med 2006 Aug 01;70(7):449-50
HSL6838
Young M.
They are more than just pretty people handing out cool pens.
Dermatol Nurs 2006 Aug 01;18(4):323-4
HSL6138
Moynihan R.
Roche defends buying lavish meals for doctors at Sydney's restaurants
BMJ 2006 Jul 22;333(7560):169
http://bmj.bmjjournals.com/cgi/content/short/333/7560/169?etoc%3e
HSL5930
Schneider JA, Arora V, Kasza K, Van Harrison R, Humphrey H.
Residents' Perceptions Over Time of Pharmaceutical Industry Interactions and Gifts and the Effect of an Educational Intervention.
Acad Med 2006 Jul 01;81(7):595-602
Link to source with long URL
HSL6882
Flewell MN.
Pharmaceutical sales reps: value beyond samples.
Adv Nurse Pract 2006 Jul 01;14(7):18
HSL6984
Standridge JB.
Of doctor conventions and drug companies.
Fam Med 2006 Jul-Aug 01;38(7):518-20
http://www.stfm.org/fmhub/fm2006/July/John518.pdf
HSL6160
Meador KJ.
Academic medical centers and conflicts of interest.
JAMA 2006 Jun 28;295(24):2845
http://jama.ama-assn.org/cgi/content/full/295/24/2845
HSL5815
Sierles FS.
The gift-giving influence
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8(6):372-376
http://www.ama-assn.org/ama/pub/category/16252.html
HSL5478
Mira AJ, Isely W, McDonnell M, Huch KM, Whittle HM, Nugent TJ, Lack DZ
Readers' Responses to "Physicians on the Take"
MedGenMed 2006 May 12
http://www.medscape.com/viewarticle/531612?src=mp
HSL6209
Dresser R.
Pharmaceutical company gifts: from voluntary standards to legal demands.
Hastings Cent Rep 2006 May-Jun 01;36(3):8-9
HSL6326
Jayaraman J.
Whose pen is in your pocket?
Can Fam Physician 2006 May 01;52:586
HSL6327
Cole D.
Whose pen is in your pocket?
Can Fam Physician 2006 May 01;52:586
HSL4517
Hill K.
Free Lunch?
The American Journal of Psychiatry 2006 Apr(163):569-570
http://ajp.psychiatryonline.org/cgi/content/full/163/4/569
HSL5649
Hill KP.
Free lunch?
Am J Psychiatry 2006 Apr;163(4):569-70
http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=16585426
HSL5501
Sikora C.
Whose pen is in your pocket?
Can Fam Physician 2006 Mar 01;52:394-5
HSL5091
Day M.
Industry association suspends drug company for entertaining doctors.
BMJ 2006 Feb 18;332(7538):381
http://bmj.bmjjournals.com/cgi/content/full/332/7538/381-a
HSL5431
Coleman DL, Kazdin AE, Miller LA, Morrow JS, Udelsman R.
Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.
Acad Med 2006 Feb 01;81(2):154-60
Link to source with long URL
HSL6339
Lazarus A.
Pharmaceutical policy issues for medical schools.
Psychiatr Serv 2006 Feb 01;57(2):167
http://ps.psychiatryonline.org/cgi/content/full/57/2/167
HSL5274
Romano M.
Fighting graft--it's academic. Medical centers must embrace conflict rules: critics.
Mod Healthc 2006 Jan 30;36(5):8-10
HSL5339
Harris G.
In article, doctors back ban on drug companies' gifts; concerns cited on quality of patient care.
NY Times (Print) 2006 Jan 25;A14
HSL5205
Day M.
UK drug companies must disclose funding of patients' groups.
BMJ 2006 Jan 14;332(7533):69
Link to source with long URL
HSL5601
Almirall N.
The ethics of engagement with the pharmaceutical industry.
Mich Med 2006 Jan-Feb;105(1):10-2
HSL6735
Morgan MA, Dana J, Loewenstein G, Zinberg S, .
Interactions of doctors with the pharmaceutical industry
J Med Ethics 2006;32:559-563
http://jme.bmjjournals.com/cgi/content/full/32/10/559
HSL5403
Anand G.
Support system: through charities, drug makers help people--and themselves.
Wall St J (East Ed) 2005 Dec 1;A1
HSL5263
Lurie P, Tran T, Wolfe SM, Goodman R.
Violations of exhibiting and FDA rules at an American Psychiatric Association annual meeting.
J Public Health Policy 2005 Dec;26(4):389-99
HSL5998
Grant DC, Iserson KV.
Who's buying lunch: are gifts to surgeons from industry bad for patients?
Thorac Surg Clin 2005 Nov 01;15(4):533-42
HSL5758
Huang FY, Weiss DS, Fenimore PG, Fleming AM, Haller E, Lichtmacher JE, Eisendrath SJ.
The association of pharmaceutical company promotional spending with resident physician prescribing behavior.
Acad Psychiatry 2005 Nov-Dec 01;29(5):500-1
http://ap.psychiatryonline.org/cgi/content/full/29/5/500
HSL5262
Komesaroff PA.
Ethical issues in the relationships with industry: an ongoing challenge. New Guidelines open for public comment.
J Paediatr Child Health 2005 Nov;41(11):558-60
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1754.2005.00719.x
HSL5296
McHenry L.
On the origin of great ideas: science in the age of big pharma.
Hastings Cent Rep 2005 Nov-Dec;35(6):17-9
HSL5063
Warrier R, Houghton B.
Doctors and the drug industry: reader feedback.
Am J Med 2005 Oct;118(10):1175-6
Link to source with long URL
HSL5254
Mahowald MW, Cramer Bornemann MA.
What? Influenced by industry? Not me!
Sleep Med. 2005 Sep 01;6(5):389-90
Link to source with long URL
HSL3942
Mansfield PR.
Banning all drug promotion is the best option pending major reforms.
J Bioethical Inquiry 2005;2(2):16-22
HSL5268
Schwartz B.
Receiving gifts: a conflict of interest discussion.
J Can Dent Assoc 2005 Sep;71(8):561-2
Link to source with long URL
HSL2732
Sharfstein SS.
Big Pharma and American Psychiatry: The Good, the Bad, and the Ugly.
Psychiatric News 2005 Aug 19;40(16):3
http://pn.psychiatryonline.org/cgi/content/full/40/16/3
HSL2733
Atkins C.
Thoughts on Pharmaceutical Companies and Gifts to Physicians
Psychiatric News 2005 Aug 19;40(16):33
http://pn.psychiatryonline.org/cgi/content/full/40/16/33
HSL5074
Chimonas S, Rothman DJ.
New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation.
Health Aff (Millwood) 2005 Jul-Aug;24(4):949-60
http://www.healthaffairs.org/
HSL1882
Brownlee S, Lenzer J.
Spin Doctored: How drug companies keep tabs on physicians.
Slate Magazine 2005 May 31
http://slate.msn.com/id/2119712/
HSL1858
Behar D, Schaller JL.
Letter to the Editor: Drug rep visits actually improve care for patients
American Medical Association News 2005-2005 May-May 23-30
HSL1859
Edwards J.
Where There's A Pill, There's A Way
Brandweek.com 2005 May 16
HSL1784
Drinkard J.
Drugmakers go furthest to sway Congress
USA TODAY 2005 Apr 25
HSL1854
Vesely R.
Medical group OKs ethics rules
San Gabriel Valley Tribune 2005 Apr 23
HSL2142
Watson PY, Khandelwal AK, Musial JL, Buckley JD.
Resident and faculty perceptions of conflict of interest in medical education.
J Gen Intern Med 2005 Apr;20(4):357-9
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.04075.x
HSL4234
Harris G.
Drug makers are still giving gifts to doctors, FDA officials tell senators.
NY Times (Print) 2005 Mar 4:A15
HSL5282
Castresana L, Mejia R, Aznar M.
[The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
Medicina (B Aires) 2005;65(3):247-51
HSL1921
Raphael MF, Bouts AH, Sukhai RN.
[Sweets from the pharmaceutical industry reason to suspect intoxication with quetiapine] .
Ned Tijdschr Geneeskd 2004 Dec 25;148(52):2583-4
HSL2214
Fitzgerald MA.
Appropriate antibiotic prescribing. Guidance for the use of drug samples
Adv Nurse Pract. 2004 Dec 01;12(12):18-22
HSL1347
Wazana A, Granich A, Primeau F, Bhanji NH, Jalbert M.
Using the literature in developing McGill's guidelines for interactions between residents and the pharmaceutical industry.
Acad Med 2004 Nov;79(11):1033-40
http://www.academicmedicine.org/cgi/content/full/79/11/1033
HSL5092
Oldani MJ.
Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
Med Anthropol Q 2004 Sep;18(3):325-56
HSL2109
Reist D, Vandecreek L.
The pharmaceutical industry's use of gifts and educational events to influence prescription practices: Ethical dilemmas and implications for psychologists
Professional psychology-research and practice 2004 Aug;35(4):329-335
HSL226
Lenzer J.
Whistleblower charges medical oversight bureau with corruption.
BMJ 2004 Jul 10;329(7457):69
http://bmj.bmjjournals.com/cgi/content/full/329/7457/69
HSL2817
Grup d'Etica Societat Catalana de Medicina Familiar i Comunitaria.
[Ethics in drug industry relations.
Opinions poll of family physicians in Catalonia]Aten Primaria 2004 Jun 15;34(1):6-12
Link to source with long URL
HSL249
Hutchinson MS.
Pharmaceutical companies and medical students: a student's view.
Med J Aust 2004 Apr 19;180(8):414
http://www.mja.com.au/public/issues/180_08_190404/hut10183_fm.html
HSL257
Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN.
The ethics of pharmaceutical industry relationships with medical students.
Med J Aust 2004 Apr 19;180(8):411-4
http://www.mja.com.au/public/issues/180_08_190404/rog10715_fm.html
HSL2803
Lakoff , A.
The anxieties of globalization: antidepressant sales and economic crisis in Argentina
Soc Stud Sci 2004 Apr;34(2):247-69
HSL1331
Zoorob R, Larzelere M.
Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know.
J La State Med Soc 2004 Jan-Feb;156(1):28-32
HSL2151
Keim S, Perina DG; CORD Board of Directors.
Council of Emergency Medicine Residency Directors position on interactions between emergency medicine residencies and the pharmaceutical industry.
Acad Emerg Med 2004 Jan;11(1):78
http://www.aemj.org/cgi/content/full/11/1/78
HSL2152
Keim SM, Mays MZ, Grant D.
Interactions between emergency medicine programs and the pharmaceutical industry.
Acad Emerg Med 2004 Jan;11(1):19-26
http://www.aemj.org/cgi/content/full/11/1/19
HSL5209
Guha A.
A comparison of codes of pharmaceutical marketing practices.
Indian J Med Ethics 2004 Jan-Mar;1(1):19-21
HSL5210
Dabade G.
Unhealthy drug donations.
Indian J Med Ethics 2004 Jan-Mar;1(1):18
HSL5213
Roy N.
Who rules the great Indian drug bazaar?
Indian J Med Ethics 2004 Jan-Mar;1(1):2-3
HSL2213
Kalb S.
[Influence of pharmaceutical advertising on the physician: A contribution to ethics in medicine].
Wurzbg Medizinhist Mitt 2004;23:446-56
HSL4242
Tengilimoglu D, Kisa A, Ekiyor A.
The pharmaceutical sales rep/physician relationship in Turkey: ethical issues in an international context.
Health Mark Q 2004;22(1):21-39
HSL1037
Katz D, Mansfield P, Goodman R, Tiefer L, Merz J.
Psychological aspects of gifts from drug companies.
JAMA 2003 Nov 12;290(18):2404-5
http://jama.ama-assn.org/cgi/content/full/290/18/2404-b
HSL1437
Gale EA.
Between two cultures: the expert clinician and the pharmaceutical industry.
Clin Med 2003 Nov-Dec;3(6):538-41
Link to source with long URL
HSL4276
Brett AS, Burr W, Moloo J.
Are gifts from pharmaceutical companies ethically problematic? A survey of physicians
Archives of Internal Medicine 2003 Oct 13;163(18):2213-2218
Link to source with long URL
HSL2426
Dana J, Loewenstein G.
A social science perspective on gifts to physicians from industry.
JAMA 2003 Jul 9;290(2):252-5
http://jama.ama-assn.org/cgi/content/full/290/2/252
HSL566
Mansfield PR.
Bribes for doctors: a gift for bioethicists?
Am J Bioeth 2003 Summer;3(3):47-8
Nil
HSL2518
Moynihan R.
Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement.
BMJ 2003 May 31;326(7400):1193-6
http://bmj.bmjjournals.com/cgi/content/full/326/7400/1193
HSL2731
Brody H.
Pens and other pharmaceutical industry gifts.
Am J Bioeth 2003 Summer;3(3):58-60
HSL2100
Zimmerman HM.
Rx for compliance. How the new PhRMA code on permissible pharmaceutical marketing practices affects your organization
MGMA Connex. 2003 Feb 01;3(2):54-7, 1.
HSL1388
Stokamer CL.
Pharmaceutical gift giving: analysis of an ethical dilemma.
J Nurs Adm 2003 Jan;33(1):48-51
HSL302
Katz D, Caplan AL, Merz JF.
All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
Am J Bioeth 2003;3(3):39-46
Link to source with long URL
HSL1450
Desmet C.
Pharmaceutical firms' generosity and physicians: legal aspects in Belgium.
Med Law 2003;22(3):473-87
Link to source with long URL
HSL1485
Wirth M, Scherer D.
Patient's perceptions of doctors' relationships with pharmaceutical companies
Healthy Skepticism International News 2002 Nov;20(11)
www.healthyskepticism.org
HSL2904
Bennett J, Collins J.
The relationship between physicians and the biomedical industries: advice from the Royal College of Physicians.
Clin Med 2002 Jul-Aug;2(4):320-2
Link to source with long URL
HSL2891
Charatan F.
Doctor sues company over unethical marketing.
BMJ 2002 May 25;324(7348):1234
http://bmj.com/cgi/content/full/324/7348/1234/b
HSL2303
Panush RS.
Not for sale, not even for rent: just say no. Thoughts about the American College of Rheumatology adopting a code of ethics.
J Rheumatol 2002 May;29(5):1049-57
http://www.jrheum.com/subscribers/02/05/1049.html
HSL2262
Spilker B.
The benefits and risks of a pack of M&Ms: A pharmaceutical spokesman answers his industry's critics
Health Affairs 2002 3-4;21(2):243-244
Link to source with long URL
HSL2896
Brody H.
A matter of influence: Changing times call for changing policies on the prescence of drug company reps in residency programs
Health Affairs (Millwood). 2002 Mar-Apr;21(2):232-234
http://www.healthaffairs.org/freecontent/s28.htm
HSL2616
Komesaroff PA, Kerridge IH.
Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry
Med J Aust 2002 Feb 4;176(3):118-21
Link to source with long URL
HSL2621
Kind M.
[Physicians--victims or promoters of corruption?].
Wien Med Wochenschr. 2002;152(9-10):249-52
Link to source with long URL
HSL2702
Hammell , D .
One hundred pennies for your thoughts
CMAJ 2001 May 15;164(10):1408
HSL2952
Nucci C.
One hundred pennies for your thoughts (1st of 2 letters)
Canadian Medical Association Journal 2001 May 15;164(10):1407
HSL2972
Hammell D.
One hundred pennies for your thoughts (2nd of 2 letters)
Canadian Medical Association Journal 2001 May 15;164(10):1407
HSL2977
Editor of CMAJ
One hundred pennies for your thoughts (response)
Canadian Medical Association Journal 2001 May 15;164(10):1407
HSL121
Stout E.
Doctoring sales
Sales & Marketing Management 2001 May:52-60
Nil
HSL2168
Steinman MA, Shlipak MG, McPhee SJ.
Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.
Am J Med 2001 May;110(7):551-7
http://linkinghub.elsevier.com/retrieve/pii/S000293430100660X
HSL2764
Goodman B.
Do drug company promotions influence physician behavior?
West J Med 2001 Apr;174(4):232-3
HSL2739
Buffett L , McCormick W
Unwanted freebies
CMAJ 2001 Feb 20;164(4):464
HSL2752
Sibbald , B .
Doctors asked to take pledge to shun drug company freebies
CMAJ 2001 Feb 01;164(4):531
HSL2741
Lal A.
Pharmaceutical drug promotion: how it is being practiced in India?
J Assoc Physicians India 2001 Feb;49:266-73
HSL122
Sigworth SK, Nettleman MD, Cohen GM.
Pharmaceutical branding of resident physicians
JAMA 2001;JAMA:1024-1025
http://jama.ama-assn.org/cgi/content/full/286/9/1024-a
HSL2986
Weber W.
Merck Sharp & Dohme prosecuted for pampering Dutch doctors
Lancet 2000 Nov 25;356:1832
HSL2991
Susman E.
No such thing as a free lunch
Scrip Magazine 2000 October;94(19)
HSL2993
Sullivan P.
Freebies to MDs targeted as drug industry starts publicizing CME fines
Canadian Medical Association Journal 2000 Sep 19;163(6):749
HSL3028
Wenger NS, Lieberman JR.
The orthopaedic surgeon and industry. Ethics and industry incentives.
Clinical Orthopaedics and Related Research 2000 September 01(378):39-43
Link to source with long URL
HSL360
Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF.
The value of pharmaceutical representative visits and medication samples in community-based family practices.
J Fam Pract 2000 Sep;49(9):811-6
Nil
HSL2998
Sams WM, Freedberg IM.
The dermatology-industry interface: defining the boundaries.
J Am Acad Dermatol 2000 Sep;43(3):550-4
Link to source with long URL
HSL1976
Wazana A.
Gifts to physicians from the pharmaceutical industry
JAMA 2000 May 24;283(20):2655-8
HSL2988
Wazana A.
Gifts to physicians from the pharmaceutical industry [1st of 2 replies]
JAMA 2000 May 24-31;283(20):2675
HSL3044
McKinney WP.
Gifts to physicians from the pharmaceutical industry [4th of 4 letters]
JAMA 2000 May 24-31;283(20):2656-7
HSL349
Guldal D, Semin S.
The influences of drug companies' advertising programs on physicians
Int J Health Serv 2000;30(3):585-95
Nil
HSL2140
Razack S, Arbour L, Hutcheon R.
Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
Ann R Coll Physicians Surg Can 1999 Mar;32(2):93-6
HSL5247
Ravindran GD.
The physician and the pharmaceutical industry: both must keep the patient's interests at heart.
Issues Med Ethics 1999 Jan-Mar;7(1):21-2
HSL2220
Gaedeke RM, Tootelian DH, Sanders EE.
Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
Health Mark Q 1999;17(1):23-31
HSL5278
Phatak A.
The pharmaceutical industry and the medical profession.
Issues Med Ethics 1998 Oct-Dec;6(4):131-2
HSL555
Bero LA.
Disclosure policies for gifts from industry to academic faculty.
JAMA 1998 Apr 1;279(13):1031-2
http://jama.ama-assn.org/cgi/content/full/279/13/1031
HSL508
So AD.
Free gifts: redundancy or conundrum?
J Gen Intern Med 1998 Mar;13(3):213-
http://www.blackwell-synergy.com/doi/full/10.1046/j.1525-1497.1998.00058.x
HSL547
Gibbons RV, Landry FJ, Blouch DL, Jones DL, Williams FK, Lucey CR, Kroenke K.
A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts.
J Gen Intern Med 1998 Mar;13(3):151-4
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.1998.00048.x
HSL708
Lewin-Fetter V.
Pharmaceutical representatives.
Lancet 1997 Dec 13;350(9093):1784
HSL720
Guyatt G.
Determining an ethical stance: Pharmaceutical industry involvement and family medicine residency training
Can Fam Physician 1997 Nov 01;43:1898-900
HSL682
Sandberg WS, Carlos R, Sandberg EH, Roizen MF.
The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products.
Acad Med 1997 Oct;72(10):916-8
Nil
HSL678
Sharfstein J.
Pfizer Night at Boston Billiards.
N Engl J Med 1997 Jul 10;337(2):134
Link to source with long URL
HSL701
Madhavan S, Amonkar MM, Elliott D, Burke K, Gore P.
The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians.
J Clin Pharm Ther 1997 Jun;22(3):207-15
Nil
HSL761
Sergeant MD, Hodgetts PG, Godwin M, Walker DM, McHenry P.
Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.
CMAJ 1996 Nov 1;155(9):1243-
HSL5947
Orlowski JP, Vinicky JK, Edwards SS.
Conflicts of interest, conflicting interests, and interesting conflicts, Part 3.
J Clin Ethics 1996 Sum 01;7(2):184-6
HSL815
Ubel PA, Arnold RM, Gramelspacher GP, Hoppe RB, Landefeld CS, Levinson W, Tierney W, Tolle SW.
Acceptance of external funds by physician organizations: issues and policy options.
J Gen Intern Med 1995 Nov;10(11):624-30
HSL1713
Blake RL Jr, Early EK.
Patients' attitudes about gifts to physicians from pharmaceutical companies.
J Am Board Fam Pract 1995 Nov-Dec;8(6):457-64
HSL832
Mainous AG 3rd, Hueston WJ, Rich EC.
Patient perceptions of physician acceptance of gifts from the pharmaceutical industry.
Arch Fam Med 1995 Apr;4(4):335-9
HSL828
Rapoport D.
Physicians and the pharmaceutical industry: under the influence?
CMAJ 1995 Jan 1;152(1):15
HSL813
Williams PA, Cockerill R, Lowy FH.
The physician as prescriber: relations between knowledge about prescription drugs, encounters with patients and the pharmaceutical industry, and prescription volume
Health and Canadian Society 1995;3:135-166
HSL847
Guyatt G.
Guidelines for interaction with the pharmaceutical industry
CMAJ 1995;152:1041-1042
HSL2689
Chren MM, Landefeld CS.
Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.
JAMA 1994 Mar 2;271(9):684-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed
HSL6472
Fassett WE.
Professional organizations and healthcare industry support: ethical conflict. Commentary
Cambridge Quarterly of Healthcare Ethics 1994;3:253-255
HSL5696
Lexchin J.
Physicians and drug companies interact.
Can Fam Physician 1993 Sep 01;39:1881-2
HSL5697
Lober CW.
Ethics in pharmaceutical advertising.
Dermatol Clin 1993 Apr 01;11(2):285-8
HSL5162
Bader , Jean-michel .
Confusion over drug-industry gifts
Lancet 1993;341:750
HSL5537
Huston P.
Doctors want more industry-sponsored meetings
Medical Marketing & Media 1993;28(3):48-50, 52-53
HSL4986
Way to irrational medical practice
HAI News 1992 Oct(67):12
HSL4988
Chetley A.
Promoting health or pushing drugs?
HAI News 1992 Oct(67):1-2, 10-12
HSL2180
Banks JW 3rd, Mainous AG 3rd.
Attitudes of medical school faculty toward gifts from the pharmaceutical industry.
Acad Med 1992 Sep;67(9):610-2
HSL4778
No free lunches here
Lancet 1992;340:365
HSL4783
Anacker A.
Pharmaceutical promotion
New England Journal of Medicine 1992;327:1686
HSL4790
Bateman CR.
Physicians and pharmaceutical companies
Canadian Medical Association Journal 1992;146:328
HSL4795
Blank IH.
Reply
Journal of Investigative Dermatology 1992;99:664-665
HSL4797
Bleidt B.
Recent issues and concerns about pharmaceutical industry promotional efforts
Journal of Drug Issues 1992;22:407-415
HSL4804
Caudill TS, Lurie N, Rich EC.
The influence of pharmaceutical industry advertising on physician prescribing
Journal of Drug Issues 1992;22:331-338
HSL4808
Chren MM.
The need for guidelines about pharmaceutical promotions involving gifts to physicians
Journal of Pharmaceutical Marketing & Management 1992;7(1):135-145
HSL4817
Ende M.
Pharmaceutical promotion
New England Journal of Medicine 1992;327:1687
HSL4821
Forrest JV.
Pharmaceutical promotion
New England Journal of Medicine 1992;327:1687
HSL4844
Kimbel KH.
Needle money
Lancet 1992;339:236-237
HSL4865
Morris LA, Griffin JP.
The evolving role of FDA in prescription drug promotion
Journal of Drug Issues 1992;22:245-256
HSL4870
Newton W, Goldstein A, Frey J.
There is no such thing as a free lunch: developing policies on pharmaceutical industry support
Journal of Family Practice 1992;34:32-34
HSL4871
Nixon AJ.
Physicians and pharmaceutical companies
Canadian Medical Association Journal 1992;146(328-329)
HSL4884
O’regan JB.
Physicians and pharmaceutical companies
Canadian Medical Association Journal 1992;146:329, 332
HSL4896
Robinson LA.
Physicians and the pharmaceutical industry
Canadian Medical Association Journal 1992;147:5822-583
HSL4897
Rogers A.
EC pharmaceutical directives
Lancet 1992;339:483
HSL4898
Rosenberg SJ.
Pharmaceutical promotion
New England Journal of Medicine 1992;327:1686
HSL4936
Wivell MK, O’fallon DA.
Drug overpromotion: when is a warning not a warning?
Trial 1992;28(11):20-27
HSL4753
Corpus JT.
Gifts to physicians from industry [5th of 5 letters]
JAMA 1991 Jul 3;266(1):62-63
HSL4754
Goldstein AO.
Gifts to physicians from industry [1st of 5 letters]
JAMA 1991 Jul 3;266(1):61
HSL4755
Leblond RF.
Gifts to physicians from industry [2nd of 5 letters]
JAMA 1991 Jul 3;266(1):61-62
HSL4756
Leung AK, Robson WM.
Gifts to physicians from industry [3rd of 5 letters]
JAMA 1991 Jul 3;266(1):62
HSL4757
McMurray RJ, Orentlicher D.
Gifts to physicians from industry [1st of 2 replies]
JAMA 1991 Jul 3;266(1):63
HSL4759
Randall T.
Gifts to physicians from industry [2nd of 2 replies]
JAMA 1991 Jul 3;266(1):63
HSL4760
Sanders JH.
Gifts to physicians from industry [4th of 5 letters]
JAMA 1991 Jul 3;266(1):62
HSL4749
Wolfe SM.
Promotional practices in the pharmaceutical industry
HAI News 1991 Jun(59):1-2, 10-11
HSL4667
Hoffman JR.
A knotty ethical dilemma
Emergency Medicine News 1991;13(5):2, 14-15
HSL4715
Venturelli J.
Medical ethics
Annals of the Royal College of Physicians and Surgeons of Canada 1991;24:161-162
HSL4716
Waugh D.
Physicians’ freebies
Canadian Medical Association Journal 1991;145:1141
HSL4717
Webber J.
Wine and cheese and CE: guidelines needed for industry sponsorship
Drug Merchandising 1991;72(4):33
HSL4631
Saade C, Huff-rousselle M.
Pakistan: should ORS be marketed like other drugs?
Dialogue on Diarrhoea 1990 Sep(42):6
HSL2194
Lurie N, Rich EC, Simpson DE, Meyer J, Schiedermayer DL, Goodman JL, McKinney WP.
Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.
J Gen Intern Med 1990 May-Jun;5(3):240-3
HSL4507
Berry J.
Doctors, drug companies, and gifts
JAMA 1990;263:2178
HSL4514
Brickler EM.
Industrial marketing and medical ethics
New England Journal of Medicine 1990;322:64
HSL4515
Burkle JS.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:407-408
HSL4522
Chren MM, Landefeld CS, Murray TH.
Doctors, drug companies, and gifts
JAMA 1990;263:2178-2179
HSL4531
Gelbart H.
Doctors, drug companies, and gifts
JAMA 1990;263:2177
HSL4532
Glass AR.
Industrial marketing and medical ethics
New England Journal of Medicine 1990;322:64
HSL4535
Gorski TN.
Doctors, drug companies, and gifts
JAMA 1990;263:2177
HSL4540
Hume AL.
Doctors, drug companies, and gifts
JAMA 1990;263:2177-2178
HSL4559
Nidiry JJ.
Doctors, drug companies, and gifts
JAMA 1990;263:2178
HSL4560
Noble RC.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:408
HSL4561
Noble RC.
The pizza parade
Annals of Internal Medicine 1990;112:237
HSL4573
Rodwin MA.
Industrial marketing and medical ethics
New England Journal of Medicine 1990;322:64
HSL4574
Roeg N.
The other drug trade
Adbusters 1990;1(4):80-87
www.adbusters.org/adbusters/
HSL4602
Venturelli J.
Medical ethics: a dilemma at our doorstep
Annals of the Royal College of Physicians and Surgeons of Canada 1990;23:335
HSL4604
Williams AP, Cockerill R.
Report on the 1989 survey of the prescribing experiences and attitudes toward prescription drugs of Ontario physicians
1990
HSL4469
Logarta JD.
Generics revisited: an overdose of expectations
Drug Monitor 1989 Apr;4(4):49-54
HSL4467
Prescriptions for profit
1989 Mar 28
HSL4412
Franklin K.
The pharmaceutical tango
New Physician 1989;38(5):24-28
HSL4422
Hershfield NB.
The ethics of physician-pharmaceutical company relationships
Canadian Medical Association Journal 1989;140:10
HSL4446
Rachlis M, Kushner C.
Second opinion: what’s wrong with Canada’s health-care system and how to fix it
1989
HSL4491
Huston P.
Those promotional dinners: food for thought?
Medical Marketing & Media 1989;24(12):78, 80, 82, 84, 86, 88, 90
HSL4073
Thompson WG.
The ethics of physician-pharmaceutical company relationships.
CMAJ 1988 Nov 1;139(9):835-6
HSL4110
Danguilan MJ.
Drug commercials scored
Drug Monitor 1988 Nov;3(11):129-130
HSL4107
Rosenthal E.
Madison Avenue medicine
Discover 1988 Oct;9(10):34-36
HSL4009
Kaufman JL.
Profligate medical marketing.
N Engl J Med 1988 Aug 25;319(8):522
HSL4022
McLeod DC.
Pharmaceutical marketing--rewriting the textbook.
Drug Intell Clin Pharm 1988 Jan;22(1):62
HSL3998
Goldfinger S.
“A matter of influence”: graduate medical education and commercial sponsorship
New England Journal of Medicine 1988;318:53
HSL4021
McGregor M.
Pharmaceutical “generosity” and the medical profession
Annals of the Royal College of Physicians and Surgeons of Canada 1988;21:289
HSL4062
Roizen R.
Why I oppose drug company payment of physician/investigators on a per patient/subject basis
IRB: a review of human subjects research 1988;10(1):9-10
HSL4072
Tan M.
Dying for drugs: pill power and politics in the Philippines
1988
HSL4122
Attanasio AE.
Medical technology in Italy
Lancet 1988;2:109
HSL3893
Katz RA.
Unhook me.
J Am Acad Dermatol 1987 Nov;17(5)
HSL3881
Graves J.
Frequent-flyer programs for drug prescribing.
N Engl J Med 1987 Jul 23;317(4):252
HSL3926
Weiss GB, Winslade WJ.
Is post-marketing drug follow-up research or advertising?
IRB 1987 Jul-Aug;9(4):10-1
HSL3888
Hilton D.
Promotion by the drug companies--should we accept their bribes?
J R Coll Gen Pract 1987 Jun;37(299):270
HSL3927
Wells F.
Promotion by the drug companies--the industry replies.
J R Coll Gen Pract 1987 Jun;37(299):270
HSL3912
Seddon TD.
Drug promotion.
N Z Med J 1987 May 27;100(824):327
HSL3887
Hay DR.
Drug promotion.
N Z Med J 1987 Apr 8;100(821):223
HSL3864
Paediatricians get their skates on
Lancet 1987;2:735
HSL3905
Mahady JM.
Frequent-flyer programs for drug prescribing
New England Journal of Medicine 1987;317:252
HSL3915
Smith R.
In delicto flagrante
Medical Journal of Australia 1987;146:322-323
HSL3855
Doctors and the drug industry [Editor's response to 3rd letter (O'Dowd & Whibley)]
British Medical Journal 1986 Nov 1;293:1171
HSL3759
Where to draw the line.
Lancet. 1986 Oct 11;2(8511):849
HSL3822
Smith R.
Doctors and the drug industry: too close for comfort.
Br Med J (Clin Res Ed) 1986 Oct 11;293(6552):905-6
HSL3819
The relationship between physicians and the pharmaceutical industry: A report of the Royal College of Physicians.
J R Coll Physicians Lond 1986 Oct;20(4):235-42
HSL3848
Lexchin J.
Good health?
New Outlook 1986 Sep-Oct:24-26, 28-31
HSL3814
Musher DM, Young EJ, Hamill RJ.
The ethics of pharmaceutical promotion.
N Engl J Med 1986 Aug 28;315(9):590
HSL3823
Spiro HM.
Mammon and medicine. The rewards of clinical trials
JAMA. 1986 Mar 7;255(9):1174-5 1986 Mar 07;255(9):1174-5
HSL3760
Akin GM.
The ethics of pharmaceutical promotion
New England Journal of Medicine 1986;315:590
HSL3816
Perkin RL.
The pharmaceutical industry
Canadian Family Physician 1986;32:2013
HSL3732
Smith R.
Doctors and the drug industry in Sweden.
Br Med J (Clin Res Ed) 1985 Feb 9;290(6466):448-50
HSL3667
Cousins J.
Payments to doctors and the responsibilities of ethics committees [2nd of 2 letters]
British Medical Journal 1984 Jan 28;288:323
HSL3668
Diamond A, Robinson K.
Payments to doctors and the responsibilities of ethics committees [1st of 2 letters]
British Medical Journal 1984 Jan 28;28:322-323
HSL3615
Drug companies at a European congress
Lancet 1984;2:1031
HSL3620
Bass MJ.
Chairman’s chair: research or marketing?
Family Medicine Research Update 1984;3(2):6-7
HSL3640
Lexchin J.
Reader upset at CFPC’s involvement in prescribing survey
Canadian Family Physician 1984;30:1454
HSL3660
Walden RJ.
Doctors and the drug makers
Lancet 1984;2:405
HSL3612
Ball JG, Snell ES.
Payments to doctors and the responsibilities of ethics committees
British Medical Journal 1983 Dec 17;287:1884
HSL3567
Drug companies and rheumatologists.
Br J Rheumatol. 1983 May 22;2:65-6
HSL3565
Doctors and the drug industry.
Br Med J (Clin Res Ed). 1983 Feb 19;286(6365):579-80
HSL3582
Goldberg D.
Tales from the Vienna Woods
Lancet 1983;2:393
HSL3585
Kass EH.
Seduction in a grand hotel
Reviews of Infectious Diseases 1983;5:973-974
HSL3596
Wright L.
Pharmaceutical advertising
New Zealand Medical Journal 1983;96:407
HSL3500
Goldbloom D.
Drug companies and medical education: a modest proposal
McGill Medical Journal 1981;46(2):24
HSL3427
Hughes R, Brewin R.
The tranquilizing of America: pill popping and the American way of life
1979
HSL3380
Muller M.
Selling health - or buying favour?
New Scientist 1977 Feb 3;73:266-268
HSL3316
Silverman M, Lee PR.
Pills, profits & politics
University of California Press 1976
HSL3237
Cooperstock R.
Some factors involved in the increased prescribing of psychotropic drugs
Alcoholism and Drug Addiction Research Foundation of Ontario 1974
HSL3176
Barnhart , R .
The medical profession-drug industry alliance
New Physician 1970;20:164-171